Table 1.
Altered bioactions of furosemide in critically ill patients with acute kidney injury.
Target abnormality | Mechanism | References |
---|---|---|
Hypoalbuminemia | Impaired furosemide delivery to nephron | 23,24 |
Loss of epithelial cell polarity | Redistribution of Na/K + ATPase, impairing secondary active transport of organic acid. | 25 |
Oliguria | Toxic plasma levels of furosemide | 26 |
Uremic organic acids accumulation | Competiton with furosemide at the OAT1/OAT3 transporter site | 27,28 |
Severe metabolic acidosis | Competiton with furosemide at the OAT1/OAT3 transporter site | 27,28 |
Elevated OAT1/OAT3 (+/−OAT4) transporter secretion in urine | Tubular damage and destruction | 29 |
Vasopressin administration | Increase expression of NKCC2 transporter and promote insertion into TAL of loop of Henle | 18,30 |
Cephalosporin administration | Competition with furosemide at the OAT1/OAT3 transporter site | 27,28 |